Please ensure Javascript is enabled for purposes of website accessibility

Show Me the Money, IMAX

By Seth Jayson – Updated Apr 6, 2017 at 12:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All cash flow is not created equal.

Although headlines still spray earnings figures all over the media every day, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to eyeball the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.

Calling all cash flows
It's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That brings us to IMAX (Nasdaq: IMAX), which has produced $23 million in FCF over the trailing 12 months, compared to $45 million in net income.


That means that IMAX turned 10% of its revenues into FCF. That seems very impressive. But, it always pays to compare that figure to sector and industry peers and competitors, to see how your company stacks up. IMAX doesn't have much in the way of direct competition, but we can take a look at how other movie and movie technology firms are doing.

Company

LTM Revenue

TTM FCF

TTM FCF Margin

 Dolby Laboratories (NYSE: DLB)

 $859

 $308

36%

 Walt Disney (NYSE: DIS)

 $36,782

 $3,675

10%

 Cinemark Holdings (NYSE: CNK)

 $2,062

 $48

2%

 Regal Entertainment Group (NYSE: RGC)

 $2,890

 N/A

0%

TTM = trailing 12 months.

Among its competitors and peers, sound specialist Dolby Laboratories comes in with the highest FCF margin (defined as FCF / trailing 12 months' revenue), with 36% of its revenues turning into FCF. IMAX manages to equal diverse Disney's take, while the results from Cinemark Holdings and Regal Entertainment Group show how tough the theater business can be.

All cash is not equal
Unfortunately, the cash flow statement isn't immune from nonsense, either. That's why it pays to take a close look at the components of cash flow from operations, to make sure that the cash comes from high-quality sources. They need to be real and replicable in the upcoming quarters, rather than being offset by continual cash outflows that don't appear on the income statement (such as major capital expenditures). For instance, cash flow based on cash net income and adjustments for non-cash income-statement expenses (like depreciation) is generally favorable. An increase in cash flow based on stiffing your suppliers (by increasing accounts payable) or shortchanging Uncle Sam on taxes will come back to bite investors. The same goes for decreasing accounts receivable; this is good to see, but it's ordinary in recessionary times, and you can only increase collections so much.

So, how does the cash flow at IMAX look? Take a peek at the chart below, which flags questionable cash flow sources with a red bar.


When I say "questionable cash flow sources," I mean line items such as changes in taxes payable, tax benefits from stock options, and asset sales, among others. That's not to say that companies booking these as sources of cash flow are weak, or are engaging in any sort of wrongdoing, or that everything that comes up questionable in my graph is automatically bad news. But whenever a company is getting more than, say, 10% of its cash from operations from these dubious sources, I feel obliged to crack open the filings and dig even deeper, to make sure I'm in touch with its true cash profitability.

With questionable cash sources comprising 22% of the cash flow from operations for IMAX, I think it's time to do a little more digging. The majority is adjustment for stock-based compensation -- typical for a youngish technology company.

A Foolish final thought
If you take the time to read past the headlines and crack a filing now and then, you're probably ahead of 95% of the market's individual investors. By keeping an eye on the health of your companies' cash flow, you can spot potential trouble early, or figure out whether the numbers merit Mr. Market's pessimism. Let us know what you think of the health of the cash flows at IMAX in the comments box below. Or, if you're itching to learn more, head on over to our quotes page to view the filings directly.

At the time of publication, Seth Jayson had no position in any company mentioned here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Walt Disney is a Motley Fool Inside Value pick. IMAX is a Motley Fool Rule Breakers recommendation. Walt Disney and Dolby Laboratories are Motley Fool Stock Advisor selections. Try any of our Foolish newsletters today, free for 30 days. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Walt Disney Company Stock Quote
The Walt Disney Company
DIS
$98.12 (-1.39%) $-1.38
IMAX Corporation Stock Quote
IMAX Corporation
IMAX
$14.03 (1.15%) $0.16
Cinemark Holdings, Inc. Stock Quote
Cinemark Holdings, Inc.
CNK
$11.86 (-2.06%) $0.25
Dolby Laboratories, Inc. Stock Quote
Dolby Laboratories, Inc.
DLB
$67.46 (-0.81%) $0.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.